Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2007
CompletedFirst Posted
Study publicly available on registry
February 9, 2007
CompletedSeptember 10, 2007
September 1, 2007
February 7, 2007
September 5, 2007
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Males or females \> 50 years old
- Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
You may not qualify if:
- · Prior use of topical ketorolac
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ophthalmic Consultants of Long Island
Rockville Centre, New York, 11570, United States
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Donnenfeld
Ophthalmic Consultants of Long Island
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 7, 2007
First Posted
February 9, 2007
Last Updated
September 10, 2007
Record last verified: 2007-09